AR016993A1
(en )
2001-08-01
INTRANASAL FORMULATIONS TO TREAT SEXUAL DISORDERS
AR037109A1
(en )
2004-10-20
USE OF FLIBANSERINE
CY1106239T1
(en )
2011-06-08
CONTROLLED-RELEASE PHARMACEUTICAL FORMULATIONS CONTAINING A cGMP PDE-5 INHIBITOR
AR048833A1
(en )
2006-05-31
PROCEDURE FOR THE TREATMENT OF PREMENSTRUAL DISORDERS AND OTHER FEMALE SEXUAL DISORDERS
UA95447C2
(en )
2011-08-10
Method of human female contraception
ECSP034519A
(en )
2003-04-25
XANTINA PHOSPHODIESTERASE V INHIBITORS
IL153492A0
(en )
2003-07-06
Treatment of male sexual dysfunction
HN2002000299A
(en )
2002-11-21
DERIVATIVES OF 3- AZABICICLO [3.1.0] HEXANO
MY124786A
(en )
2006-07-31
Bis-arylsulfones
GB0225908D0
(en )
2002-12-11
Treatment of female sexual dysfunction
MY133446A
(en )
2007-11-30
Treatment of impotence due to spinal cord injury
NO20062883L
(en )
2006-08-18
Phosphodiesterase V inhibitorpreparater
ECSP993027A
(en )
1999-08-12
INTRANASAL FORMULATIONS FOR SEXUAL DISORDERS
HUP0400528A2
(en )
2004-06-28
Use of neuropeptidaz inhibitor for preparation of pharmaceutical conposition suitable for treatment of male sexual dysfunction
IL166273A0
(en )
2006-01-15
Methods of treatment of male erectile dysfunction
GB2386555B
(en )
2005-10-12
Treatment of female sexual dysfunction
UY27426A1
(en )
2003-04-30
SILDENAFIL MALEATE
ECSP993165A
(en )
1999-11-29
PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION
IL162822A0
(en )
2005-11-20
Treatment of male sexual dysfunction
ES2092685T3
(en )
1996-12-01
USE OF ATIPAMEZOL FOR THE TREATMENT OF MALE SEXUAL IMPOTENCE.
ES1048488Y
(en )
2001-12-16
MECHANICAL DEVICE FOR PROLONGING THE ERECTION OF THE PENIS.
GB0108483D0
(en )
2001-05-23
Treatment of male sexual dysfunction
GB0120679D0
(en )
2001-10-17
Treatment of male sexual dysfunction
GB0108730D0
(en )
2001-05-30
Treatment of male sexual dysfunction
GB0106167D0
(en )
2001-05-02
Treatment of male sexual dysfunction